期刊文献+

TNF结合肽和TNFR封闭肽的筛选及其鉴定 被引量:4

Screening and Identification of TNF-α Binding Peptide and TNFR Blocking Peptide
下载PDF
导出
摘要 目的筛选能与TNF-α结合的环肽(称为TNF结合肽)以及既能与TNFR-Ⅰ结合又不诱导TNFR相关生物学效应的环肽(称为TNFR封闭肽)。方法采用噬菌体随机肽库展示技术分别以hrTNF-α和hrTNFRⅠ为诱饵进行亲和筛选,ELISA方法进行噬菌体特异性鉴定,应用细胞毒抑制实验和RT-PCR技术等进行噬菌体的生物学效应鉴定。根据噬菌体展示肽的DNA序列合成环肽。结果对肽库进行3轮筛选后,噬菌体克隆具有良好的富集效果;5种TNF结合噬菌体克隆(5、6、7、32及38号克隆)和2种TNFR封闭噬菌体(X2、X4号克隆)分别能与TNF-α和TNFR特异性结合,并且均能显著抑制sTNF-α对L929细胞和U937细胞的杀伤作用,TNFR封闭噬菌体不仅本身无促进U937细胞IL-1βmRNA转录的作用,而且还能有效抑制sTNF-α的生物学效应;并且发现X4与32号、X4与38号联用的细胞毒抑制效应均较其单独作用的效果好,其中X4与38号联用的抑制率高达85.3%,显著高于各自单独的抑制作用(P<0.01)。选择32、38和X4号噬菌体克隆进行DNA测序并合成环肽。结论从噬菌体随机环肽库中筛选得到能够抑制sTNF-α生物学功能的TNF结合肽和TNFR封闭肽,为研制TNF相关的多肽类抗炎药物奠定了实验基础。 Objective To screen and identify both TNF-α binding peptide and TNFR blocking peptide and study their biological functions. Methods The soluble hrTNF-αand hrTNFR I were used respectively as a specific bait to screen phage peptide library. ELISA was used to identify the specificity of the selected phage clones. The inhibition test of eytotoxicity of TNF- α and RT-PCR were used to evaluate the biological functions of the selected clones. Results After three rounds of bio-panning, the selected phage clones showed better enrichment result. Five phage clones (No. 5 No. 6, No. 7, No. 32 and No. 38) and 2 phage clones (No. X2 and No. X4) were identified as the potent TNF-αbinding phages and TNFR blocking phages separately. Both phages could inhibit the cytotoxicity of L929 and U937 induced by sTNF obviously. TNFR blocking phages not only could inhibit the cytotoxicity induced by sTNF, but also had no effect to increase the level of IL-1β mRNA induced by TNF-α. The inhibition rate of cytotoxicity of the combination of clones No. X4 and No. 32, clones No. X4 and No. 38 was significantly higher than that of individual phage clones, among them the combination of clones No. 38 and No. X4 exerted higher inhibition rate (85.30 %) of cytotoxicity compared to clone No. 38 or No. X4 alone (P〈0.01). This result indicated that TNF-α binding phages and TNFR blocking phages worked synergically. Clones No. 32, No. 38 and No. X4 were sequenced in order to determine the amino acid sequences of peptides, and the cycle peptides of clones No. 32, No. 38 and No. X4 were then synthesized. Conclusion The TNF-α binding peptide and TNFR blocking peptide obtained by phage display technique could block the biological activity of the TNF-α, which may provide an important clue for the development of novel TNF related anti-inflammatory peptide drug.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2005年第6期670-673,677,共5页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家高科技研究发展计划("863"计划)资助项目(No.2001AA215431)
关键词 噬菌体肽库 肿瘤坏死因子-Α 肿瘤坏死因子结合肽 肿瘤坏死因子受体封闭肽 phage peptide library tumor necrosis factor-α tumor necrosis factor-α binding peptide tumor necrosis factor receptor blocking peptide
  • 相关文献

参考文献13

  • 1LamK S,SalmaonSE,Hersh E M etal.A new type of syntheyic peptide library fo identifying ligand binding activity.Nature,1991,354:82.
  • 2Scott J K,Smith G P.Searching for peptide ligands with an epitope library.Science,1990,249:386.
  • 3Zaccone P,Fehervari Z.Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNFreceptor type Ⅰ.EurJ Immunol,2002,32:1021.
  • 4Kekow J,Welte T.Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.Arthritis Rheum,2002,46:843.
  • 5Chiang K Y,Abhyankar S.Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease.Transplantation,2002,73:665.
  • 6Deeg H J,Gotlib J.Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome:a pilot study.Leukemia,2002,16:162.
  • 7Carina M.,David L V.Signalling by CD95 and TNF receptors:not only life and death.Immuno Cell Bio,1999,77:41.
  • 8Michael K,Anning L.NF-κB at the crossroads of life and death.Nat Immunol,2002,3:221.
  • 9熊霞辉,喻明霞,石文芳,李清芬,林莉,冯玮,徐勇,李卓娅.噬菌体展示TM-TNF-α模拟肽体内杀瘤效应的研究[J].中华微生物学和免疫学杂志,2005,25(4):282-285. 被引量:1
  • 10Baert F,Noman M,Vermeire S et al.Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.N Engl J Med,2003,348:601.

二级参考文献5

同被引文献41

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部